
Cabot Corporation
- Jurisdiction
United States - LEI
K05C0SER542GQ6VLRO68 - ISIN
US1270551013 (CBT )- Sectors
Scores
- Fair value (Benjamin Graham formula)
-
€84.80 31.5% undervalued - Financial strength (Piotroski F-Value)
-
5
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
5
/ 7
Profile
Cabot Corporation operates as a specialty chemicals and performance materials company. Read full profile
Fundamentals
- Net revenue
€3.25B - Gross margin
25.2% - EBIT
€540.77M - EBIT margin
16.6% - Net income
€362.50M - Net margin
11.1%
Statement period: - (published )
Estimates
Fiscal Year | Net revenue | Net income |
---|---|---|
|
| |
|
| |
N/A | N/A |
Stock price
Dividends
- Last dividend amount
-
$0.45 - Ex date
-
- Payment date
-
- Dividend payout ratio
-
22.4%
Analyst ratings
No analyst ratings available
Insider Transactions
Name | Title | Transaction Date | Shares | Price | Value |
---|---|---|---|---|---|
Keohane Sean D | President and CEO |
|
|
|
|
Earnings Calls
Investor transactions
Name | Shares | Value | Last change | Change type |
---|---|---|---|---|
Peter Brown |
|
|
|
Sell |
Ray Dalio |
|
|
|
Buy |
Earnings Calls
Latest earnings call: August 5, 2025 (Q3 2025)